Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Nat Med. 2022 Feb 17;28(5):1050–1062. doi: 10.1038/s41591-022-01724-3

Figure 3 -. Proteomic analysis in MIS-C compared to pCOVID-19.

Figure 3 -

a, b, Upregulated (panel a) and downregulated (panel b) plasma proteins obtained from the comparison between pCOVID-19 (n=10) and pHC (n=4).

c, d, Top 25 up- and down-regulated plasma proteins obtained from the comparison between MIS-C (within the first 7 days of hospitalization, n=16) and pHC (n=4).

e, f, Top 25 up- and down-regulated plasma proteins obtained from the comparison between MIS-C (within the first 7 days of hospitalization, n=16) and pCOVID-19 (n=10).

g, Median predictive importance values derived from random forest regression of soluble biomarker values in a group of 101 samples obtained at various time points after hospitalization from 38 MIS-C patients who received both systemic glucocorticoids and IVIG, and in another group of 57 samples from 25 MIS-C patients who received systemic glucocorticoids only. In each random forest regression model (composed of 1000 decision trees with one model per target), predictive importance value for each predictor-target pair is computed using the algorithm described in ref.66.

In panels a-f, top up- and down-regulated proteins were identified by selecting all proteins with false discovery rate (FDR) <0.05 and p value <0.05 (two-tailed t-test), and then ordering them according to increased or decreased fold-changes expressed in a log2 scale. Heatmaps show the most significantly enriched pathways for the group comparison and the statistical significance is expressed as -log(p value).